Each year, the US Food and Drug Administration (FDA) approves far fewer health technologies for use in children than adults. This means that pediatric specialists do not always have access to the advanced tools they need to address the unique healthcare needs of their small, vulnerable patients. Stanford launched Impact1 to improve the health, safety, and quality of life of pediatric patients and pregnant women. We do this by accelerating the development and availability of high-value, high-impact pediatric health technologies. The program leverages Stanford Biodesign’s need-driven innovation process to accomplish this goal. It benefits from access to world-renowned clinicians and engineers at Stanford, as well as an unparalleled network of Silicon Valley experts in medical device product development, regulatory affairs, intellectual property, reimbursement, and commercialization. Our team also represents the Stanford collaborators of the UCSF-Stanford Pediatric Device Consortium.
External link for Impact1 at Stanford Biodesign
Stanford, US
Congratulations Gravitas - now FDA cleared for neonatal use!
We are pleased to announce FDA Clearance of the Gravitas Entarik device for NEONATES! This is a big step in improving the safety and efficacy of enteral nutrition for neonates. https://lnkd.in/gs2ZBXGP
🌟 After Much Anticipation, We're Excited to Unveil... impact4kids! 🌟 Today, we’re thrilled to announce the transatlantic partnership between i4KIDS I i4KIDS-EUROPE and Impact1 at Stanford Biodesign – an innovation initiative dedicated to advancing #pediatric and #maternal health across the U.S. and European Union. ➡ Impact4Kids is uniquely bridging innovation ecosystems, fostering collaboration, and empowering health innovators to make a real difference where it matters most. ⬅ Starting December 2, we will accept applications for projects from the European Union and the United States. Selected projects will ✅ enter a 6-month online program ✅ have access to expert coaching sessions to develop, validate, and implement strategies tailored to both U.S. and European markets. ✅ be immersed in a virtual ecosystem that connects participants with key players in healthcare innovation. Stay tuned for more details and the application link in early December, and if you’re as excited as we are, comment below or DM us to learn more! CC: Stanford Mussallem Center for Biodesign, Barcelona Children's Hospital Sant Joan de Déu #Impact4Kids #HealthcareInnovation #Pediatrics #MaternalHealth #Collaboration #InnovationEcosystems
Bon dia de Barcelona - hi from the capital of Catalunya, Spain! The wonderful team from i4KIDS I i4KIDS-EUROPE hosted us today at the innovation hub of the renowned Children’s Hospital Sant Joan de Déu Barcelona. We are so excited for the Pediatric Innovation Day tomorrow! #pediatricinnovation #collaboration
🎉 What an incredible experience earlier this week at the 2024 Pediatric MedTech CEO Summit in NYC! The energy in the Cure building was electric, and the sense of community was truly wonderful. Impact1 co-director Janene Fuerch kicked off the day and set the perfect tone. Leaders and innovators came together to connect during lively discussions, hear from thought-provoking panels, and share struggles and successful stories on their path to tackling some of the biggest challenges in pediatric healthcare. A huge thank you to Emma Moran and the team at CobiCure and Deerfield Management for making this event such a success, especially the speakers and panelists who brought so much expertise and energy. And, of course, to all the attendees—your dedication and collaboration make this mission possible. Here’s to building a better future for pediatric healthcare! Let’s keep the momentum going. 🚀👶💡 #PediatricHealthcare #MedTech #Innovation #Leadership #Collaboration #HealthcareLeadership with: Janene Fuerch Kunj Sheth Juliana Perl Marta Arenas-Jal, PhD Ignacio Pérez Sophia Brodsky, BSN, RN Austin Sawyer Antje Kirschner
Thrilled to have the Impact1 team in NYC for the CobiCure CEO Summit! 🚀 Great discussions on driving innovation, scaling impact, and exploring new opportunities to transform lives from day 1. It’s inspiring to connect with leaders who share our vision of a healthier, more sustainable future. Exciting things ahead—stay tuned! #Impact1 #NYC #healthcare #innovation
We recommend this webinar on #pediatric #innovation, which will be hosted by Stanford Mussallem Center for Biodesign in just over 10 days!
🗓️ Join us on Wednesday November 20 for our last Innovation & Health Equity discussion of the year! In “Scaling Innovations for Health Equity: A Conversation with Global Strategies”, Dr. Joshua Bress, president of the nonprofit Global Strategies, together with their partners from the Democratic Republic of Congo and Uganda will share the journey behind NoviGuide —one of the largest neonatal digital health platforms in the world that has redefined neonatal care in over 41 hospitals and clinics in low- and middle-income countries, delivering over 125,000 assessments each year. They will discuss the importance of diverse user testing and the opportunities presented by cross-country partnerships. ⏰ Date: November 20th 9 AM (PST) ➡️Register to attend the webinar here: bit.ly/3TTGFSK 💬 Submit your questions in advance using the space in the registration form. CC: Bay Area Global Health Alliance, Stanford Center for Innovation in Global Health
“There may be a lot of competition in other medical device spaces, but in pediatrics, everyone's trying to help you succeed, and I think that's something intangible that investors can't quantify, but it is a valuable intangible that exists.” For our third episode of Impact1 Voices, we had a great conversation with Beverly Tang, CEO of Starlight Cardiovascular: a company developing a portfolio of devices for babies born with congenital heart disease. In this episode, Beverly discusses the synergies involved in building a multi-product company, creative fundraising methods, and how to conduct needs finding without formal ties to a health system. If you are an entrepreneur interested in the pediatric space, don’t miss this story! Listen on Apple Podcasts and Spotify: 🟣 apple.co/3XRLvBp 🟢 spoti.fi/3zSSySa #healthtech #healthinnovation #podcast #maternalhealth #pediatric #biodesign CC: Stanford Mussallem Center for Biodesign
“There may be a lot of competition in other medical device spaces, but in pediatrics, everyone's trying to help you succeed, and I think that's something intangible that investors can't quantify, but it is a valuable intangible that exists.” For our third episode of Impact1 Voices, we had a great conversation with Beverly Tang, CEO of Starlight Cardiovascular: a company developing a portfolio of devices for babies born with congenital heart disease. In this episode, Beverly discusses the synergies involved in building a multi-product company, creative fundraising methods, and how to conduct needs finding without formal ties to a health system. If you are an entrepreneur interested in the pediatric space, don’t miss this story! Listen on Apple Podcasts and Spotify: 🟣 apple.co/3XRLvBp 🟢 spoti.fi/3zSSySa #healthtech #healthinnovation #podcast #maternalhealth #pediatric #biodesign CC: Stanford Mussallem Center for Biodesign
In the world of pediatric and maternal health, sometimes the best inspirations are fueled by embracing a little childlike wonder ourselves... #HappyHalloween from the family at Impact1 to yours! #StayPlayful #MedTechInnovation #PediatricHealth #MaternalHealth
Tomorrow from 10am-2pm ET, all are welcome to join the “Essentials of Startup Law” Bootcamp. Thanks to our friends at the Midwest Pediatric Device Consortium for sharing this opportunity with early innovators.